Stem cell collection may predict MDS risk in myeloma patients

08/22/2013 | MyelomaBeacon.com

The risk of developing myelodysplastic syndrome was more than three times greater for myeloma patients who receive transplants of stem cells gathered after an initial transplant compared with cases where the stem cells were collected beforehand, according to a study from the University of Arkansas for Medical Sciences. Overall, the timing of stem cell collection did not affect survival, researchers reported in the journal Leukemia.

View Full Article in:

MyelomaBeacon.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ